Pharma

Judge Ends 'Unlawful' 340B Reimbursement Timeline
A judge rejected HHS' stated plan to wait until January 1 to restore drug payment rates to 340B hospitals.
Evaluating the Risk of Nitrosamines: Zantac's 4-Year-Old Recall Is Still Affecting Industry.
The pharmaceutical industry has yet to discover how nitrosamines occur in its drugs and how to mitigate the risk of...

Get the latest on healthcare leadership in your inbox.

Research Finds Some Hospitals Are Raising The Cost of Cancer Drugs
Forty-four percent of hospitals view the 340B Drug Pricing Program as a critical revenue source.
Pioneer in Castleman's Disease Launches Nonprofit Drug Repurposing Organization
David Fajgenbaum and Grant Mitchell unveil Every Cure at Clinton Global Initiative.
Researchers Develop a Digital Health Wearable That Can Track Tumor Size
Researchers from Stanford, USC, Georgia Tech, and the University of Tokyo have developed a battery-powered digital health wearable that attaches...
Judge: Suboxone 'Product Hopping' LawSuit May Proceed
The suit alleges that Indivior violated antitrust laws to preserve its Suboxone monopoly.
Increased contraceptive education can help manage impact of Roe vs. Wade
The effects of the SCOTUS Dobbs ruling are being felt across the industry.
FDA Accelerated Approval Expands Enhertu Indication to NSCLC
AstraZeneca/Daiichi drug becomes first specifically approved for HER2 mutant NSCLC.
Alzheimer’s treatment slowed cognitive decline in closely watched clinical trial
An investigational Alzheimer's disease treatment from Biogen and Eisai slowed the rate of cognitive decline by 27% in a clinical...
Biogen stock explodes higher after potential 'mega blockbuster' Alzheimer's drug study
Biogen stock is booming amid as Wall Street speculates about a potential profit boom after a promising study detailed the...
Walgreens pharmacies suddenly close, causing confusion in Cambridge
Walgreens says their pharmacies on River Road and Mass Ave in Cambridge were forced to close for three days over...
Biden Medicare costs victory due mostly to Alzheimer's drug change
U.S. President Joe Biden claimed victory on Tuesday for a drop in costs for tens of millions of Americans covered...
Pfizer, Moderna seek authorization for updated COVID-19 boosters for younger children
Pfizer and BioNTech completed their submission to the FDA for emergency use authorization of their updated COVID-19 booster for children...
Biogen will pay $900M over kickback allegations
Cambridge-based Biogen will pay $900 million to settle allegations that it paid doctors to prescribe its drugs.
Load More